HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.

Abstract
Non-alcoholic fatty liver disease (NAFLD) is associated with obesity and lifestyle, while exercise is beneficial for NAFLD. Dysregulated microRNAs (miRs) control the pathogenesis of NAFLD. However, whether exercise could prevent NAFLD via targeting microRNA is unknown. In this study, normal or high-fat diet (HF) mice were either subjected to a 16-week running program or kept sedentary. Exercise attenuated liver steatosis in HF mice. MicroRNA array and qRT-PCR demonstrated that miR-212 was overexpressed in HF liver, while reduced by exercise. Next, we investigated the role of miR-212 in lipogenesis using HepG2 cells with/without long-chain fatty acid treatment (± FFA). FFA increased miR-212 in HepG2 cells. Moreover, miR-212 promoted lipogenesis in HepG2 cells (± FFA). Fibroblast growth factor (FGF)-21, a key regulator for lipid metabolism, was negatively regulated by miR-212 at protein level in HepG2 cells. Meanwhile, FFA downregulated FGF-21 both at mRNA and protein levels in HepG2 cells. Also, FGF-21 protein level was reduced in HF liver, while reversed by exercise in vivo. Furthermore, siRNA-FGF-21 abolished the lipogenesis-reducing effect of miR-212 inhibitor in HepG2 cells (± FFA), validating FGF-21 as a target gene of miR-212. These data link the benefit of exercise and miR-212 downregulation in preventing NAFLD via targeting FGF-21.
AuthorsJunjie Xiao, Yihua Bei, Jingqi Liu, Jasmina Dimitrova-Shumkovska, Dapeng Kuang, Qiulian Zhou, Jin Li, Yanning Yang, Yang Xiang, Fei Wang, Changqing Yang, Wenzhuo Yang
JournalJournal of cellular and molecular medicine (J Cell Mol Med) Vol. 20 Issue 2 Pg. 204-16 (Feb 2016) ISSN: 1582-4934 [Electronic] England
PMID26648452 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Chemical References
  • Fatty Acids
  • MicroRNAs
  • RNA, Messenger
  • fibroblast growth factor 21
  • Fibroblast Growth Factors
Topics
  • Animals
  • Cell Line, Tumor
  • Diet, High-Fat (adverse effects)
  • Down-Regulation (genetics)
  • Fatty Acids (metabolism)
  • Fibroblast Growth Factors (genetics, metabolism)
  • Hep G2 Cells
  • Humans
  • Lipid Metabolism (genetics)
  • Liver (metabolism, pathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs (genetics)
  • Non-alcoholic Fatty Liver Disease (genetics, metabolism, pathology)
  • Physical Conditioning, Animal (physiology)
  • RNA, Messenger (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: